INSP Deadline Alert: Hagens Berman Notifies Inspire Medical Systems Investors of Today’s Lead Plaintiff Deadline in Securities Class Action

National investor rights law firm Hagens Berman Sobol Shapiro LLP issued an urgent announcement on January 5, 2026, alerting investors in Inspire Medical Systems, Inc. (NYSE: INSP) to the final deadline to seek appointment as lead plaintiff in a pending securities class action lawsuit. The Lead Plaintiff Deadline is today, January 5, 2026, and the firm is urging shareholders who suffered substantial losses to contact its attorneys promptly. The lawsuit, filed in the U.S. District Court for the District of Minnesota, alleges that Inspire Medical and certain executives made materially false or misleading statements and failed to disclose critical operational failures related to the launch of its next‑generation sleep apnea device, Inspire V. According to the complaint, the company purportedly assured the market of the device’s operational readiness while concealing issues such as Medicare billing software problems, excess inventory of older devices, and insufficient training and onboarding at implant centers. These undisclosed issues allegedly contributed to major revenue bottlenecks, a significant guidance cut, and a sharp decline in INSP’s stock price, including a drop of approximately $42.04 per share (about 32.4%). The Class Period covers investors who acquired INSP securities between August 6, 2024 and August 4, 2025. Investors who believe they suffered losses are encouraged to contact Reed Kathrein of Hagens Berman to discuss their legal rights and potential participation in the case. #InspireMedical #INSPClassAction #SecuritiesFraud #LeadPlaintiffDeadline #SlimScan #GrowthStocks #CANSLIM